| COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer (NCT06790589) | AHS Cancer Control Alberta | 2026-12-01 |
| Radiation Treatment of the Prostate That is Specially Adjusted for Each Person (NCT07578519) | AHS Cancer Control Alberta | 2026-06-01 |
| PET/MRI in Rectal Cancer (NCT06057831) | AHS Cancer Control Alberta | 2026-05-01 |
| This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung Cancer (NCT06882174) | AHS Cancer Control Alberta | 2026-05-01 |
| PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer (NCT07291557) | AHS Cancer Control Alberta | 2026-05-01 |
| Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC) (NCT05128734) | AHS Cancer Control Alberta | 2026-04-01 |
| Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer (NCT07330583) | AHS Cancer Control Alberta | 2026-03-01 |
| Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis (NCT06860542) | AHS Cancer Control Alberta | 2026-02-10 |
| Steroid Sparing in Immune Related Hepatitis (irH) (NCT05345847) | AHS Cancer Control Alberta | 2025-12-08 |
| Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) (NCT05407987) | AHS Cancer Control Alberta | 2025-04-08 |
| BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma (NCT05538988) | AHS Cancer Control Alberta | 2024-12-01 |
| Loratadine for the Prevention of G-CSF-related Bone Pain (NCT05421416) | AHS Cancer Control Alberta | 2024-11-28 |
| High Heated Humidity in Stem Cell Transplant (NCT05358262) | AHS Cancer Control Alberta | 2024-11-05 |
| Nutritional Supplementation in Head and Neck Cancers (NCT05379712) | AHS Cancer Control Alberta | 2024-10-25 |
| Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) (NCT05663775) | AHS Cancer Control Alberta | 2024-08-20 |
| Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1) (NCT06001125) | AHS Cancer Control Alberta | 2024-08-12 |
| SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases (NCT05775146) | AHS Cancer Control Alberta | 2024-06-18 |
| GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02) (NCT06789081) | AHS Cancer Control Alberta | 2024-02-01 |
| Prognostic Indicators for Radiation-induced Breast Fibrosis (NCT05031065) | AHS Cancer Control Alberta | 2024-01-24 |
| A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer (NCT05712174) | AHS Cancer Control Alberta | 2023-09-14 |
| GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (NCT06827886) | AHS Cancer Control Alberta | 2023-09-06 |
| PSMA-PET/CT Registry (NCT05709535) | AHS Cancer Control Alberta | 2023-07-11 |
| Pilot Trial for Treatment of Recurrent Glioblastoma (NCT05432518) | AHS Cancer Control Alberta | 2023-06-27 |
| Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer (NCT05040815) | AHS Cancer Control Alberta | 2023-05-11 |
| Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2) (NCT05413473) | AHS Cancer Control Alberta | 2023-02-08 |
| A Nutritional Supplement to Support People With Non-small Cell Lung Cancer (NCT04175769) | AHS Cancer Control Alberta | 2022-12-19 |
| Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients (NCT04765514) | AHS Cancer Control Alberta | 2022-07-27 |
| Exercise and Compression for Lymphedema (NCT05022823) | AHS Cancer Control Alberta | 2022-06-29 |
| Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer (NCT04952480) | AHS Cancer Control Alberta | 2022-06-13 |
| A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys (NCT04990895) | AHS Cancer Control Alberta | 2022-03-30 |
| Tamoxifen Versus Etoposide After First Recurrence in GBM Patients (NCT04765098) | AHS Cancer Control Alberta | 2022-01-28 |
| iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT04808791) | AHS Cancer Control Alberta | 2021-10-27 |
| mHealth Physical Activity Intervention for Young Cancer Survivors (NCT04765241) | AHS Cancer Control Alberta | 2021-09-27 |
| Pre- Versus Post-operative SRS for Resectable Brain Metastases (NCT04474925) | AHS Cancer Control Alberta | 2021-09-27 |
| Immune-Mediated Pathophysiology And Clinical Triage Program (NCT04354649) | AHS Cancer Control Alberta | 2021-09-16 |
| MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1) (NCT04358913) | AHS Cancer Control Alberta | 2021-08-23 |
| Participating in Tai Chi to Reduce Anxiety and Keep up Physical Function (NCT05452824) | AHS Cancer Control Alberta | 2021-06-21 |
| Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases (NCT04461418) | AHS Cancer Control Alberta | 2021-03-30 |
| Study of Niacin in Glioblastoma (NCT04677049) | AHS Cancer Control Alberta | 2021-03-18 |
| Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions (NCT04242589) | AHS Cancer Control Alberta | 2021-03-03 |
| Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation (NCT04328246) | AHS Cancer Control Alberta | 2021-02-26 |
| p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT) (NCT04104945) | AHS Cancer Control Alberta | 2021-01-12 |
| Virtual Overdose Response (NCT04391192) | AHS Cancer Control Alberta | 2020-09-01 |
| HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis (NCT03456817) | AHS Cancer Control Alberta | 2020-07-01 |
| A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment (NCT04268199) | AHS Cancer Control Alberta | 2020-05-29 |
| Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma (NCT04107103) | AHS Cancer Control Alberta | 2020-03-19 |
| A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use (NCT03145857) | AHS Cancer Control Alberta | 2020-03-05 |
| A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast Cancer (NCT04149444) | AHS Cancer Control Alberta | 2020-02-01 |
| Chemoradiotherapy for Advanced Esophageal Cancer (NCT02297217) | AHS Cancer Control Alberta | 2019-11-21 |
| Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting (NCT03831178) | AHS Cancer Control Alberta | 2019-08-28 |
| The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy (NCT03737721) | AHS Cancer Control Alberta | 2019-04-12 |
| Unilateral Neck Radiotherapy in Head and Neck Cancer (NCT03622164) | AHS Cancer Control Alberta | 2018-12-21 |
| A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. (NCT03469011) | AHS Cancer Control Alberta | 2018-09-18 |
| Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP) (NCT03391973) | AHS Cancer Control Alberta | 2018-08-24 |
| Avelumab With Valproic Acid in Virus-associated Cancer (NCT03357757) | AHS Cancer Control Alberta | 2018-02-07 |
| A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely (NCT03175146) | AHS Cancer Control Alberta | 2017-09-01 |